These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 3170395)

  • 1. Activity of penems against methicillin-resistant Staphylococcus aureus.
    Fontana R
    J Antimicrob Chemother; 1988 Jul; 22(1):86. PubMed ID: 3170395
    [No Abstract]   [Full Text] [Related]  

  • 2. Activity of penems against methicillin-resistant Staphylococcus aureus.
    Holt HA; Bywater MJ; Reeves DS
    J Antimicrob Chemother; 1988 Jul; 22(1):87-8. PubMed ID: 3170396
    [No Abstract]   [Full Text] [Related]  

  • 3. Activity of penems against methicillin-resistant Staphylococcus aureus.
    Van der Auwera P
    J Antimicrob Chemother; 1988 Sep; 22(3):385-7. PubMed ID: 3182431
    [No Abstract]   [Full Text] [Related]  

  • 4. [In vitro synergism of two-drug combinations among cefamandole, flomoxef and imipenem against MRSA].
    Inoue M; Sakurai N; Matsui H; Tsunoda M; Okubo T
    Jpn J Antibiot; 1990 Feb; 43(2):233-8. PubMed ID: 2362351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activity of FCE 22101 against methicillin-resistant Staphylococcus aureus and affinity for penicillin binding proteins.
    Piddock LJ; Traynor EA; Wise R
    J Antimicrob Chemother; 1989 Mar; 23 Suppl C():59-64. PubMed ID: 2732144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 5,6-Cis-penems: broad-spectrum anti-methicillin-resistant Staphylococcus aureus beta-lactam antibiotics.
    Ishiguro M; Tanaka R; Namikawa K; Nasu T; Inoue H; Nakatsuka T; Oyama Y; Imajo S
    J Med Chem; 1997 Jul; 40(14):2126-32. PubMed ID: 9216830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stemphones, novel potentiators of imipenem activity against methicillin-resistant staphylococcus aureus, produced by Aspergillus sp. FKI-2136.
    Koyama N; Nagahiro T; Yamaguchi Y; Masuma R; Tomoda H; Omura S
    J Antibiot (Tokyo); 2005 Nov; 58(11):695-703. PubMed ID: 16466023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Incidence, frequency and resistance characteristics of methicillin-oxacillin resistant Staphylococcus aureus strains in Germany].
    Voss A; Machka K; Lenz W; Milatovic D
    Dtsch Med Wochenschr; 1992 Dec; 117(50):1907-12. PubMed ID: 1459021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility of methicillin-resistant Staphylococcus aureus to imipenem and other antimicrobial agents.
    Ishag AJ; Durgham SM; Shibl AM
    Chemioterapia; 1987 Aug; 6(4):261-3. PubMed ID: 3477333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
    Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
    J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic resistance pattern of Staphylococcus aureus with special reference to methicillin resistant strains.
    Chakravarty A; Talwar V; Gupta H
    Indian J Med Res; 1988 Jun; 87():570-2. PubMed ID: 3240936
    [No Abstract]   [Full Text] [Related]  

  • 12. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Chambers HF; Sachdeva M; Kennedy S
    J Infect Dis; 1990 Sep; 162(3):705-10. PubMed ID: 2387996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Evaluation of susceptibility to antibiotics of Staphylococcus aureus strains resistant to methicillin].
    Trzciński K; Grzesiowski P; Marusak T; Zareba T; Tyski S; Hryniewicz W
    Med Dosw Mikrobiol; 1992; 44(3-4):93-6. PubMed ID: 1305928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyslabdan, a new potentiator of imipenem activity against methicillin-resistant Staphylococcus aureus, produced by Streptomyces sp. K04-0144. II. Biological activities.
    Fukumoto A; Kim YP; Hanaki H; Shiomi K; Tomoda H; Omura S
    J Antibiot (Tokyo); 2008 Jan; 61(1):7-10. PubMed ID: 18305353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomally-encoded aminoglycoside resistance in methicillin-resistant Staphylococcus aureus.
    Jordens JZ; Hall LM; Naidoo J
    J Hosp Infect; 1988 Aug; 12(2):134-6. PubMed ID: 2905719
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro antibacterial activity of TOC-50, a new parenteral cephalosporin against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Nomura S; Hanaki H; Unemi N
    Chemotherapy; 1996; 42(4):253-8. PubMed ID: 8804792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibacterial activity of imipenem in combination with ampicillin against methicillin-resistant strains of Staphylococcus aureus].
    Saionji K; Shitara M; Miyake N; Inoue K; Kobayashi I
    Jpn J Antibiot; 1990 Oct; 43(10):1685-97. PubMed ID: 2086811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of pristinamycin against methicillin-resistant Staphylococcus aureus.
    Mutton KJ; Andrew JH
    Chemotherapy; 1983; 29(3):218-24. PubMed ID: 6409520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibacterial activity of FCE 22101 against relatively resistant blood culture isolates.
    Qadri SM; Ueno Y; Ellis ME
    Chemotherapy; 1991; 37(1):15-22. PubMed ID: 2013238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Susceptibility of Hong Kong isolates of methicillin-resistant Staphylococcus aureus to antimicrobial agents.
    French GL; Ling J; Ling T; Hui YW
    J Antimicrob Chemother; 1988 May; 21(5):581-8. PubMed ID: 3391861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.